Form 10 Explorer
10-Q
Quarterly Report
VITASPRING BIOMEDICAL CO., LTD.

CIK: 1697884

File #: 333-216645

Period End: Apr 30, 2025

Fiscal Year: 2026

View on EDGAR
Balance Sheet
25 line items · 2 periods
XBRL
ItemApr 30, 2025Jan 31, 2025
BALANCE SHEETS (Unaudited)
ASSETS
CURRENT ASSETS
Cash
0272
Other Non-Operating Current Assets
2950
Total current assets
295272
LONG-TERM ASSET
Property, Plant and Equipment
11,61714,106
Total long-term asset
11,61714,106
Total assets
11,91214,378
LIABILITIES AND STOCKHOLDERS' DEFICIT
CURRENT LIABILITIES
Accounts Payable
2,411,0002,411,000
Other Non-Operating Current Liabilities
530,498494,751
Taxes Payable
325,116313,722
Advances from related party
841,039810,105
Total current liabilities
4,107,6534,029,578
Total liabilities
4,107,6534,029,578
COMMITMENTS AND CONTINGENCIES
00
STOCKHOLDERS' DEFICIT
Total Stockholders' Equity
20,70320,703
Total Stockholders' Equity
1,245,6001,245,600
Total Stockholders' Equity
(5,362,044)(5,281,503)
Total stockholders' deficit
(4,095,741)(4,015,200)
Total liabilities and stockholders' deficit
11,91214,378